Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

369 results about "Oxetane" patented technology

Oxetane, or 1,3-propylene oxide, is a heterocyclic organic compound with the molecular formula C₃H₆O, having a four-membered ring with three carbon atoms and one oxygen atom. The term "an oxetane" or "oxetanes" refer to any organic compound containing the oxetane ring.

Methods for treating immune thrombocytopenia by administering (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Methods for treating immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (PRN1008) and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising at least one compound chosen from PRN1008 and pharmaceutically acceptable salts thereof are also disclosed.
Owner:PRINCIPIA BIOPHARMA INC

Methods for treating persistent or chronic immune thrombocytopenia in children, adolescents and adults by administering (r)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy- phenyl)pyrazolo[3,4-d]pyrimidin-l-YL]piperidine-l-carbonyl]-4- methyl-4-[4-(oxetan-3-YL)piperazin-l-YL]pent-2-enenitrile

Methods for treating children, adolescents and adults with persistent or chronic immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof are disclosed.
Owner:PRINCIPIA BIOPHARMA INC

UV-cured wind power blade repair resin and preparation method thereof

PendingCN119220052Acontrollable responseImplement patchingPolymer scienceUV curing
The invention belongs to the technical field of composite prepreg, and relates to UV curing wind power blade repairing resin and a preparation method thereof.The repairing resin comprises a component A and a component B. The component A comprises, by weight, 0-60 parts of glycidyl epoxy resin, 30-80 parts of alicyclic epoxy resin, 0-20 parts of oxetane and 2-30 parts of flexibilizer; the component B is prepared from the following components in parts by weight: 90 to 99 parts of olefin monomer or olefin resin, 0.1 to 6 parts of free radical photoinitiator, 0.1 to 2 parts of thermal cationic initiator and 0.1 to 5 parts of photo cationic initiator. The UV-cured wind power blade repair resin is a hybrid system of an epoxy resin system and acrylate resin, has the advantages of light curing of epoxy resin and acrylate resin, does not need heating or solvent, is controllable in reaction degree, can be quickly formed at low temperature, and has the repair thickness gt; and the material can be applied to repair in winter and other severe environments.
Owner:YANTAI DONGHUA MATERIAL SCI CO LTD

Cationic epoxy resin photocuring adhesive as well as preparation method and application thereof

The invention relates to the technical field of photocuring materials, in particular to a cationic epoxy resin photocuring adhesive as well as a preparation method and application thereof. The cationic epoxy resin photocuring adhesive provided by the invention is prepared from the following components in percentage by weight: 25 to 55 percent of alicyclic epoxy resin, 10 to 25 percent of organic silicon modified alicyclic epoxy resin, 10 to 25 percent of oxetane, 5 to 20 percent of abietate dihydric alcohol, 5 to 10 percent of adhesion promoter, 0.3 to 3 percent of sensitizer and 0.1 to 2 percent of photoacid generator. The cationic epoxy resin light-cured adhesive provided by the invention is applied to bonding of electronic materials, has the advantages of high adhesive force and high elongation, particularly has higher adhesive force to copper materials than conventional cationic epoxy adhesives, overcomes the defects of conventional cationic light-cured adhesives, and is excellent in cured product performance, high in aging reliability and wide in application range.
Owner:YANTAI DARBOND TECH +2

Photo-curing epoxy ink as well as preparation method and application thereof

The invention provides light-cured epoxy ink and a preparation method and application thereof, the light-cured epoxy ink comprises an alicyclic epoxy monomer, an oxetane monomer, a diluent, a photoinitiator, an adhesion promoter and an assistant, the alicyclic epoxy monomer is an alicyclic epoxy monomer containing more than two polycyclic rings in a molecule; and the adhesion promoter is glycidyl ether epoxy micromolecules containing hydroxyl groups. According to the epoxy ink composition disclosed by the invention, the rigid group alicyclic ring and the adhesion promoter with hydroxyl are introduced, so that the epoxy ink composition has high adhesion and film surface hardness at the same time. The light-cured printing ink provided by the invention has low viscosity and high light transmittance. The liquid crystal composition is suitable for the field of display panels such as OLEDs, Micro-LEDs and the like, and the ink-jet printing technology is met.
Owner:WANHUA CHEM GRP CO LTD

Curable composition, cured product, adhesive, and sealant

Provided are: a curable composition that has, at high standards, curability, mechanical strength, and low viscosity; a cured product of the same; an adhesive; and a sealant. The curable composition contains an epoxy-oxetane compound represented by chemical formula (I). In the formula, the Rs are the same or different, and each represents a hydrogen atom or a C1-3 alkyl group.
Owner:SHIKOKU CHEM CORP

High-bending-strength flexible graphite bipolar plate micropore plugging agent

The invention discloses a high-bending-strength flexible graphite bipolar plate micropore plugging agent which comprises the following components in parts by weight: 20-30 parts of glycidyl ether oxypropyl cyclotetrasiloxane, 70-80 parts of oxetane or alicyclic epoxy resin, 0.1-2.0 parts of a cationic thermal initiator and 0.5-2 parts of a flatting agent, and the sum of the parts by weight of the two is 100. The flexible graphite bipolar plate plugging agent has excellent ethylene glycol resistance due to an organosiloxane structure, and each molecule of glycidyl ether oxypropyl cyclotetrasiloxane contains four epoxy groups capable of being subjected to cationic curing, so that after curing, the flexible graphite bipolar plate plugging agent is high in crosslinking density, good in heat resistance, low in curing shrinkage rate and small in residual stress; compared with a (methyl) acrylate plugging agent, the plugging agent has higher bending strength.
Owner:SUZHOU HAOBANG NEW MATERIAL CO LTD

Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor

Solid forms of the compound, 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine, and solid forms of salts or co-crystals of Compound I, were prepared and characterized:Also provided are processes of making the solid forms and methods of use thereof.
Owner:IGNOTA LABS LTD

Production of plant diterpenoids

PCT designated stage expiredWO2024251968A1CytochromesEnzymesOxetaneDiterpenoid synthesis
The present invention relates to the field of plant diterpenoid synthesis, and in particular methods and host cells therefor. More specifically, the invention relates to production of taxanes comprising an oxetane, taxanes comprising an oxetane and acetoxy group and taxanes hydroxylated at position 10, 11 and / or 13, as well as enzymes and host cells useful for such production.
Owner:UNIVERSITY OF COPENHAGEN

Thermosetting epoxy adhesive for photovoltaic 0BB technology and application of thermosetting epoxy adhesive

The invention discloses a thermosetting epoxy adhesive for a photovoltaic 0BB technology. The thermosetting epoxy adhesive comprises the following components in parts by mass: 10-20 parts of castor oil structure oxetane, 30-70 parts of alicyclic epoxy, 1-10 parts of polyester polyol, 1-5 parts of hydrogenated rosin resin, 0.6-3 parts of a thermal initiator, 0.5-1.5 parts of a coupling agent, 0.2-1.0 part of an anti-aging agent and 1-7 parts of a thixotropic agent. The thermosetting epoxy glue for the photovoltaic 0BB technology has the advantages of good yellowing resistance, low volatile matter at high temperature and good high and low temperature impact performance.
Owner:YANTAI DARBOND TECH

Halogenated alcohol dehalogenase mutant and synthesis method of chiral gamma-amino alcohol

PendingCN121271831ABacteriaHydrolasesDehalogenaseNucleophile
The invention provides a halohydrin dehalogenase mutant and an application of the halohydrin dehalogenase mutant in synthesis of a chiral gamma-amino alcohol compound. Halogenated alcohol dehalogenase mutants enabling 2-substituted oxetane to be subjected to ring opening are obtained through the technologies of gene mining, directed evolution and the like, and the enzymes can directly perform ring opening on a substrate 2-aryl oxetane under the action of a nucleophilic reagent to generate a series of chiral gamma-amino alcohol compounds which are important precursors for synthesizing drugs. Therefore, the halohydrin dehalogenase mutants have important application value in the industry.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI +1

Methods for Treating Immune Thrombocytopenia By Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enentrile

Methods for treating immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof are disclosed.
Owner:PRINCIPIA BIOPHARMA INC

Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl) pyrazolo[3,4-d] pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl) piperazin-1-yl]pent-2-enenitrile

Modified release formulations, such as solid oral dosage forms comprising a core composition comprising Compound (I) and / or a pharmaceutically acceptable salt thereof; a sub-coating layer coating the core composition, said sub-coating layer comprising a polyvinyl alcohol and / or a hydroxypropyl methyl cellulose; and an enteric coating layer encapsulating the sub-coating layer and the core composition, said enteric coating layer comprising at least one polymer selected from an acrylic / methacrylic / ethacrylic acid homopolymer and copolymers thereof, a cellulose derivative, and a polyvinylpyrrolidone, and methods of administration of a Bruton's tyrosine kinase (BTK) inhibitor using said formulations.
Owner:PRINCIPIA BIOPHARMA INC

Cationic epoxy resin light-curing adhesive and preparation method and application thereof

The present invention relates to the technical field of photocurable materials, and in particular to a cationic epoxy resin photocurable adhesive and a preparation method and application thereof. The cationic epoxy resin photocurable adhesive provided by the present invention comprises the following components by weight percentage: 25-55% alicyclic epoxy resin, 10-25% organosilicon-modified alicyclic epoxy resin, 10-25% oxetane, 5-20% rosin ester diol, 5-10% adhesion promoter, 0.3-3% sensitizer, and 0.1-2% photoacid generator. The cationic epoxy resin photocurable adhesive provided by the present invention is used in the bonding of electronic materials, and has the advantages of high adhesion and high elongation, especially the adhesion to copper materials is higher than that of conventional cationic epoxy adhesives, which solves the defects of conventional cationic photocurable adhesives, and the cured product has excellent performance, high aging reliability, and a wide range of applications.
Owner:YANTAI DARBOND TECH +2

Process of making 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy- phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4- methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile and solvate forms thereof

PCT designated stage expiredWO2025029842A8Organic active ingredientsAntipyreticPiperazidinePhenyl group
Disclosed herein are novel methods for preparing 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile, including various solvate forms and intermediates thereof. Also disclosed herein are novel solvate forms and intermediates of 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile.
Owner:PRINCIPIA BIOPHARMA INC

Polyurethane adhesive with fluorine-containing side chain and preparation method thereof

The invention discloses a polyurethane adhesive with a fluorine-containing side chain and a preparation method thereof, and relates to a polyurethane adhesive and a preparation method thereof. The invention aims to solve the problem that energy loss is caused by reduction of AP high-energy components due to the fact that common fluorine-containing polymers such as PVDF and PTFE are usually added in the form of an oxidizing agent due to limitation of inherent characteristics of the fluorine-containing polymers. The preparation method comprises the following steps: step 1, purging a reaction container for 30 minutes by using high-purity nitrogen, adding an initiator and a solvent, adding a catalyst A, and mixing and reacting for 10-60 minutes; step 2, dropwise adding a fluorine-containing oxetane monomer into the reaction liquid; step 3, adding branched-chain fluorine-containing hydroxyl-terminated polyether PFOH, diisocyanate and triisocyanate into the container, stirring for 5-30 minutes, adding a catalyst B, uniformly stirring, pouring into a silica gel mold, and putting into a vacuum oven at room temperature to remove bubbles; and step 4, putting the mold into a heating oven. The invention belongs to the technical field of polyurethane synthesis.
Owner:无锡海特新材料研究院有限公司

Preparation method of (S)-oxetane-2-methylamine

The invention provides a preparation method of (S)-oxetane-2-methylamine. The preparation method of (S)-oxetane-2-methylamine comprises the following steps: (1) carrying out ring closing reaction on a compound A under an alkaline condition to obtain a compound B; (2) reacting the compound B with dibenzylamine to obtain a compound C; (3) reacting the compound C with a reducing agent to obtain a compound D; (4) reacting the compound D with paratoluensulfonyl chloride to obtain a compound E; (5) reacting the compound E with alkali to obtain a compound F; and (6) carrying out a reaction on the compound F and palladium on carbon to obtain the (S)-oxetane-2-methylamine. According to the preparation method provided by the invention, ring expansion reaction using trimethylsulfoxide iodide in the prior art is avoided, the problem that residual sulfur elements cause poisoning of a palladium-carbon catalyst is solved, meanwhile, sodium azide is also avoided, and the preparation method is safe and reliable in process, high in chiral purity and yield and suitable for industrial large-scale production.
Owner:SHANGHAI KELY BIOPHARMACEUTICAL CO LTD +1

Curable composition, cured product, adhesive and sealant

The present invention provides a curable composition having high levels of curability, low viscosity, and mechanical strength, as well as a cured product thereof, an adhesive, and a sealant. The curable composition contains an epoxy-oxetane compound represented by chemical formula (I), in which R may be the same or different and represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms. [Formula 1] JPEG0007588753000026.jpg3685
Owner:SHIKOKU CHEM CORP

Synthetic method of 3-aminooxetane-3-formic acid

The invention belongs to the field of medicine synthesis, and relates to a synthesis method of a medicine intermediate 3-aminooxetane-3-formic acid. The method has the advantages of cheap and easily available raw materials, non-toxic intermediate products and high yield of final products, and has industrial production prospects.
Owner:CHANGSHA HANCHEN BIOTECHNOLOGY CO LTD

Synthesis method of 3-ethyl-3-[(2-oxirane methoxy) methyl] oxetane

The invention provides a synthesis method of 3-ethyl-3-[(2-oxirane methoxy) methyl] oxetane (EGMO), and belongs to the technical field of fine chemical engineering. According to the method, sodium hydroxide is taken as an alkaline reagent, and a quaternary ammonium salt or quaternary phosphonium salt phase transfer catalyst is adopted to promote the effective contact of sodium salt and epichlorohydrin, so that the conversion process of preparing 3-ethyl-3-[(2-oxirane methoxy) methyl] oxetane from 3-ethyl-3-oxetane and epichlorohydrin is catalyzed. According to the method disclosed by the invention, the EGMO is synthesized by dropwise adding the epoxy chloropropane through a one-pot method, and a product with relatively high content and relatively low color number can be obtained without distillation, so that the reaction time is shortened, the side reaction of the epoxy chloropropane is reduced, the production efficiency, the product yield and the purity are improved, and the color number of the product is reduced. The preparation process is convenient to operate, simple and suitable for industrial production.
Owner:HUBEI JINGHONG CHEM CO LTD

Methods for Treating Immune Thrombocytopenia by Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy- Phenyl) Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile

Methods for treating immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (PRN1008) and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising at least one compound chosen from PRN1008 and pharmaceutically acceptable salts thereof are also disclosed.
Owner:PRINCIPIA BIOPHARMA INC

A bismaleimide resin composition, a prepreg and a laminate prepared therefrom

The present application relates to a kind of bismaleimide resin compositions and the semi-cured sheet and laminated plate prepared therefrom, comprising components: bismaleimide compound, allyl phenol compound and oxetane compound, the equivalent ratio range of double bond in the bismaleimide compound and double bond in the allyl phenol compound is 3~0.3, the oxetane compound accounts for 0.5~5% of the overall resin, the preparation process of semi-cured sheet and laminated plate includes the following preparation steps: step S1, the glue liquid prepared by bismaleimide resin composition is infiltrated into glass fiber cloth, and then baked and dried to obtain semi-cured sheet;Step S2, the surface of semi-cured sheet is covered with metal foil, and high-temperature pressing is formed, the advantage of the present application is that the glue liquid of resin composition, semi-cured sheet has good storage property, and the laminated plate prepared therefrom has excellent heat resistance, copper foil bonding force and moisture resistance.
Owner:RUILONG MATERIALS TECHNOLOGY (JIANGSU) CO LTD

Display panel for AR (Augmented Reality) equipment, low-refractive-index epoxy filling adhesive and preparation method of low-refractive-index epoxy filling adhesive

The invention provides an epoxy filling adhesive with a low refractive index, the epoxy filling adhesive is used for being coated between an OLED light-emitting layer and a glass cover plate of a display panel, and the epoxy filling adhesive comprises the following components in parts by mass: 1-79 parts of monofunctional fluorine-containing epoxy resin. And 1-79 parts of bifunctional fluorine-containing epoxy resin. And 1 to 50 parts of oxetane epoxy resin. And 0.1 to 1 part of a leveling agent. And 0.1 to 3 parts of an antioxidant additive. And 0.1 to 3 parts of a photoinitiator. The epoxy filling adhesive system contains fluorine atoms, the high electronegativity of the fluorine atoms enables the density of electron clouds around the fluorine atoms to be high, so that the polarizability of the epoxy filling adhesive is reduced, scattering and reflection of light rays when the light rays pass through the epoxy filling adhesive are reduced, the refractive index of the epoxy filling adhesive is reduced, and the refractive index of the epoxy filling adhesive is reduced. Therefore, when the light passes through the epoxy filling adhesive, the refracted positive visual angle is small, and the light is more concentrated when passing through the epoxy filling adhesive, the OLED light-emitting layer and the glass cover plate, so that the light-emitting brightness of the display panel is increased.
Owner:HUIZHOU SHUOBED SEMICON MATERIALS CO LTD

Formulations of 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy- phenyl)pyrazolo[3,4-d]pyrimidin-l-YL]piperidine-l-carbonyl]-4- methyl-4[4-(oxetan-3-YL)piperazin-l-YL]-pent-2-enenitrile

Disclosed herein are novel formulations of 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile, including formulations including various solid forms thereof. Also disclosed are processes for preparing formulations of 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile.
Owner:PRINCIPIA BIOPHARMA INC

Synthesis method for constructing 4-substituted isocoumarin and analogues thereof through ring opening of oxetane

ActiveCN119371416AOrganic chemistryPharmaceutical SubstancesIsocoumarin
The invention relates to the technical field of medicine preparation, discloses a synthesis method for constructing 4-substituted isocoumarin and analogues thereof through ring opening of oxetane, and synthesizes a series of isocoumarin derivatives. Comprising isocoumarin derivatives with 4-position hydroxymethyl substitution and 4-position amidomethyl substitution, and isocoumarin series compounds composed of five-membered heteroaromatic rings and dihydropyrone, and the synthesized isocoumarin series compounds have a plurality of functionalization sites, can be used as common intermediates in pharmaceutical chemistry research to rapidly provide series derivatives, and can be used for preparing the isocoumarin series compounds. Reaction raw materials and reagents used are convenient and easy to obtain and low in price, reaction conditions in the reaction process are mild, the process is simple, harsh conditions such as high temperature and high pressure are not needed, and the generated product does not contain metal ions, is convenient to separate and purify and is suitable for large-scale production in factories.
Owner:SHANGHAI DEGRON BIOMEDICAL TECH CO LTD

Resin composition, adhesive agent, sealing material, cured product, semiconductor device, and electronic component

The present invention addresses the problem of providing: a resin composition that is capable of at least being photocured or being cured at low temperature (for example, 100°C or less) and that provides a cured product that exhibits excellent adhesive strength and high heat-resistance reliability; an adhesive agent or a sealing material that includes the same; a cured product thereof; and a semiconductor device and an electronic component that include the cured product. Provided are: a resin composition containing (A) an epoxy compound, (B) an oxetane compound, and (C) an acid-generating agent that is a salt of an anion represented by formula (1) (In the formula, R1, R2, R3, and R4 independently represent an alkyl group having 1-18 carbon atoms or an aryl group having 6-14 carbon atoms, provided, however, that at least one of R1, R2, R3, and R4 represents an aryl group having 6-14 carbon atoms.) and of a counter cation, and also satisfying at least one of the following characteristics (a) and (b); an adhesive agent or a sealing material including the same; a cured product thereof; and a semiconductor device and an electronic component including the cured product. (a) (D) A filler is further included. (b) The content of (A) the epoxy compound is 100-1300 parts by weight with respect to 100 pats by weight of (B) the oxetane compound.
Owner:NAMICS CORPORATION